Drugs in metabolic disease therapy are cheap and treatments are well established. Yet, current prevention and therapy does hardly account for the complexity and multifactorial character of the underlying processes. This has resulted in a therapy which is almost entirely focused on decreasing (symptomatic) risk factors, instead of targeting the underlying causal processes in a personalized manner, a surprisingly ineffective medical care!
Flow Chemistry